Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|July 30, 2022
Based on 0.35 T magnetic resonance-guided radiotherapy, what are the nonisotropic PTV margins required for conventional prostate radiotherapy?Joseph Drabble, Prantik Das, Ben George, et al.
Cancers|August 10, 2024
The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)Elena Moreno-Olmedo, Ami Sabharwal, Prantik Das, et al.
Advances in Radiation Oncology|September 3, 2024
Stereotactic Magnetic Resonance-Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity OutcomesKillian Nugent, Prantik Das, Dan Ford, et al.
Clinical Genitourinary Cancer|April 19, 2024
Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Renal Cell Carcinoma in England: A Retrospective Cohort StudyPrantik Das, Alison Booth, Robert Donaldson, et al.
BJUI Compass|April 27, 2022
Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective study of real-world data (ACES)Prantik Das, Sarah Taylor, James Price, et al.
BMJ Open|July 20, 2022
Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UKHeather Ann Payne, Suneil Jain, Clive Peedell, et al.
Clinical and Translational Radiation Oncology|January 15, 2026
Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomesElena Moreno-Olmedo, Dan Murray, Ben George, et al.
Current Oncology Reports|April 23, 2024
Antibody Drug Conjugates in Urological Cancers: A Review of the Current LandscapeAruni Ghose, Patricia Lapitan, Vedika Apte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT TrialAlison Jane Birtle, Robert Jones, John Chester, et al.
British Journal of Cancer|April 21, 2026
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trialAnderley Gordon, Amina Tran, Caroline Fong, et al.
Pageof 2